Fluorometric monitoring of the effects of adrenergic agents on oxidative metabolism in intact cerebral cortex.
D000818:Animals; D002415:Cats; D002540:Cerebral Cortex / Q000378:metabolism* / Q000648:ultrastructure; D002746:Chlorpromazine / Q000494:pharmacology*; D003913:Dextroamphetamine / Q000494:pharmacology*; D005260:Female; D005470:Fluorometry; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D008928:Mitochondria / Q000378:metabolism; D010084:Oxidation-Reduction; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*
D008694:Methamphetamine; D012110:Reserpine; D011433:Propranolol; D007545:Isoproterenol; D003913:Dextroamphetamine; D002746:Chlorpromazine